Biogen Inc
LSE:0R1B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
PetroFrontier Corp
XTSX:PFC
|
CA |
|
U
|
Universal Microelectronics Co Ltd
TWSE:2413
|
TW |
|
D
|
Digitree Group SA
WSE:DTR
|
PL |
Wall Street
Price Targets
0R1B Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for
0R1B
is 208.93 USD
with a low forecast of 143.42 USD and a high forecast of 271.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0R1B's stock price target?
Price Target
208.93
USD
According to Wall Street analysts, the average 1-year price target for
0R1B
is 208.93 USD
with a low forecast of 143.42 USD and a high forecast of 271.1 USD.
What is Biogen Inc's Revenue forecast?
Projected CAGR
-1%
For the last 14 years the
compound annual growth rate for
Biogen Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
-1%.
What is Biogen Inc's Operating Income forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Biogen Inc's operating income is
2%.
The projected
CAGR
for the next 3 years is
3%.
What is Biogen Inc's Net Income forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Biogen Inc's net income is
0%.
The projected
CAGR
for the next 3 years is
26%.
